Printed from the IBC Life Sciences Web site on April 16, 2014 6:21 PM ET.
Page location: http://www.ibclifesciences.com/news/index.xml
Page 5 of 7
IBC's Biopharmaceutical Development & Production Week will feature FDA and EMEA Feedback from QbD Case Study on Wednesday, March 3, 2010. Results from the CMC Biotech Working Group will be presneted presented by Eli Lilly and Company and Pfizer Inc.
G. Steven Burrill will be presenting a keynote presentation entitled "Life Sciences Navigating the Sea Change" on Thursday, March 4, 2010 at IBC's Antibody Development & Production conference.
IBC Life Sciences is pleased to announce Biopharmaceutical Development & Production Week, which includes five conferences bringing in perspectives from multiple biopharmaceutical disciplines all under one roof.
IBC's Annual Well Characterized Biologicals conference is dedicated to bringing the freshest content to the industry to help drive forward protein characterization efforts and new technology implementation: FDA perspectives, case studies, unpublished new data...
Today IBC Life Sciences kicks off its annual BioProcess International™ Conference & Exhibition in Raleigh, North Carolina with over 1,500 pharmaceutical, biotechnology, government and academic researchers, executives and technology providers expected to attend.
Copyright IBC Life Sciences, a part of Informa Life Sciences Group.